These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


289 related items for PubMed ID: 10282090

  • 1. The effect of pharmacy intervention on aminoglycoside costs.
    Tsuyuki RT, Nakagawa RS.
    Can J Hosp Pharm; 1987 Apr; 40(2):51-6. PubMed ID: 10282090
    [Abstract] [Full Text] [Related]

  • 2. Financial impact of an aminoglycoside substitution program.
    Andrews JD, Stad K.
    Can J Hosp Pharm; 1987 Feb; 40(1):23-6. PubMed ID: 10281256
    [Abstract] [Full Text] [Related]

  • 3. Controlling cephalosporin and aminoglycoside costs through pharmacy and therapeutics committee restrictions.
    Hayman JN, Sbravati EC.
    Am J Hosp Pharm; 1985 Jun; 42(6):1343-7. PubMed ID: 4014250
    [Abstract] [Full Text] [Related]

  • 4. Cost-benefit analysis of an aminoglycoside monitoring service.
    Kimelblatt BJ, Bradbury K, Chodoff L, Aggour T, Mehl B.
    Am J Hosp Pharm; 1986 May; 43(5):1205-9. PubMed ID: 3087162
    [Abstract] [Full Text] [Related]

  • 5. Cost savings associated with use of gentamicin versus tobramycin.
    Schwinghammer TL, Romano MJ, Wing EJ.
    Am J Hosp Pharm; 1985 Aug; 42(8):1745-9. PubMed ID: 4036972
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacist interventions to improve prescribing of vancomycin and tobramycin.
    Fletcher CV, Giese RM, Rodman JH.
    Am J Hosp Pharm; 1986 Sep; 43(9):2198-201. PubMed ID: 3766572
    [Abstract] [Full Text] [Related]

  • 8. Altering aminoglycoside selection in a community hospital.
    Mioduch HJ, Burnakis TG.
    Hosp Formul; 1987 Feb; 22(2):182-6. PubMed ID: 10280290
    [Abstract] [Full Text] [Related]

  • 9. Effect of aminoglycoside-use restrictions on drug cost.
    DeTorres OH, White RE.
    Am J Hosp Pharm; 1984 Jun; 41(6):1137-9. PubMed ID: 6430070
    [Abstract] [Full Text] [Related]

  • 10. Cost containment through therapeutic substitution of aminoglycosides.
    Guernsey BG, Berina LF, Lazarus MC, Hokanson JA, Prohaska C, Allen JA, Doutre WH, Mader JT.
    Hosp Pharm; 1985 Feb; 20(2):82-3, 86-92, 95. PubMed ID: 10270312
    [Abstract] [Full Text] [Related]

  • 11. Antibiotic surveillance: the results of a clinical pharmacy intervention program.
    Capers CC, Bess DT, Branam AC, Falbe WJ, Mrochek SA, Haymond JD, Stahl AA.
    Hosp Pharm; 1993 Mar; 28(3):206-10, 212. PubMed ID: 10124947
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Aminoglycoside use monitored by clinical pharmaceutical services.
    Barriere SL, Conte JE.
    Am J Hosp Pharm; 1979 Sep; 36(9):1209-11. PubMed ID: 495621
    [Abstract] [Full Text] [Related]

  • 17. Pharmacy-laboratory interactions: a unique method to control antibiotic costs.
    Goff D, Thornton J.
    Hosp Pharm; 1989 Jan; 24(1):26-9, 32. PubMed ID: 10291600
    [Abstract] [Full Text] [Related]

  • 18. An aminoglycoside monitoring service in a community hospital using a microcomputer.
    Voytovich RM, Outten RL.
    Hosp Pharm; 1987 Mar; 22(3):267-72. PubMed ID: 10281372
    [Abstract] [Full Text] [Related]

  • 19. Effect of antibiotic order form guiding rational use of expensive drugs on cost containment.
    Sirinavin S, Suvanakoot P, Sathapatayavongs B, Malatham K.
    Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):636-42. PubMed ID: 10437971
    [Abstract] [Full Text] [Related]

  • 20. A targeted review of vancomycin use.
    Piquette RK.
    Can J Hosp Pharm; 1991 Apr; 44(2):83-7. PubMed ID: 10111726
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.